These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11855392)

  • 1. Monitoring safety of over the counter drugs. Over the counter medicines must be treated like all other medicines.
    Walmsley J; Marshall G
    BMJ; 2002 Feb; 324(7334):424-5. PubMed ID: 11855392
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring safety of over the counter drugs. Patients could do more than just treat themselves.
    Wade AG
    BMJ; 2002 Feb; 324(7334):424-5. PubMed ID: 11850381
    [No Abstract]   [Full Text] [Related]  

  • 3. Over-the-counter product line extensions: have we reached the limit yet?
    Sansgiry SS
    J Am Geriatr Soc; 2004 Jul; 52(7):1223-4. PubMed ID: 15209675
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring the safety of over the counter drugs.
    Henry DA; McEwen J
    Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1414. PubMed ID: 3121035
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK.
    Layton D; Sinclair HK; Bond CM; Hannaford PC; Shakir SA
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):503-13. PubMed ID: 12426936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Societal perspectives on over-the-counter (OTC) medicines.
    Wazaify M; Shields E; Hughes CM; McElnay JC
    Fam Pract; 2005 Apr; 22(2):170-6. PubMed ID: 15710640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues related to monitoring the safety of over-the-counter (OTC) medicines.
    Bond C; Hannaford P
    Drug Saf; 2003; 26(15):1065-74. PubMed ID: 14640771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postmarketing surveillance studies in community pharmacies].
    Nieber K; Lehmacher W
    Med Monatsschr Pharm; 2009 Aug; 32(8):301-6. PubMed ID: 19777737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world].
    Yang W; Xie Y; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2779-82. PubMed ID: 22292363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-the-counter medicines.
    Erwin J; Britten N; Jones R
    Br J Gen Pract; 1996 Feb; 46(403):121-2. PubMed ID: 8855022
    [No Abstract]   [Full Text] [Related]  

  • 11. Is it time to regulate over-the-counter weight-loss formulations?
    Hackett A; Krska J
    Int J Pharm Pract; 2012 Jun; 20(3):199-202. PubMed ID: 22554163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-marketing strategies for medicines.
    Breckenridge A
    Clin Pharmacol Ther; 2008 Jan; 83(1):24-5; discussion 25. PubMed ID: 18043682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis on correlation between sales of over-the-counter drugs and the incidence of influenza-like-illness].
    Guo JH; Zhou JK; Feng SQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):307-8. PubMed ID: 18788537
    [No Abstract]   [Full Text] [Related]  

  • 14. OTC survival guide. FAQs on OTCs. Here are answers to your questions about over-the-counter remedies.
    Quartetti HR
    Diabetes Forecast; 2004 Feb; 57(2):68-71. PubMed ID: 14976939
    [No Abstract]   [Full Text] [Related]  

  • 15. Are H2 receptor antagonists safe over the counter drugs?
    Andersen M; Schou JS
    BMJ; 1994 Aug 20-27; 309(6953):493-4. PubMed ID: 8086898
    [No Abstract]   [Full Text] [Related]  

  • 16. Revised product labels for pediatric over-the-counter cough and cold medicines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1180. PubMed ID: 18971921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency.
    Laliberté MC; Normandeau M; Lord A; Lamarre D; Cantin I; Berbiche D; Corneille L; Prud'homme L; Lalonde L
    Am J Kidney Dis; 2007 Feb; 49(2):245-56. PubMed ID: 17261427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time for evidence-based labelling of over-the-counter medicines.
    MacLennan AH; Sturdee DW
    Climacteric; 2007 Jun; 10(3):179-80. PubMed ID: 17487644
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety of over-the-counter drugs: some reflections and unanswered questions.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 2003 Apr; 23(2):111-2. PubMed ID: 12640210
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring the safety of over the counter drugs.
    Volans GN
    Br Med J (Clin Res Ed); 1987 Oct; 295(6602):797-8. PubMed ID: 3119043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.